Adoptive T-cell transfer therapy was first attempted in the late 1980s to early 1990s, following the identification of the first tumor associated antigens and isolation of tumor reactive CD8+ T-cell clones from cancer patients. This evidence concerns the gene CD8A and neoplasm.